AGTHX
Price
$79.64
Change
-$9.51 (-10.67%)
Updated
Feb 3 closing price
Net Assets
335.97B
RWGFX
Price
$4.24
Change
-$0.66 (-13.47%)
Updated
Feb 3 closing price
Net Assets
28.48M
Interact to see
Advertisement

AGTHX vs RWGFX

Header iconAGTHX vs RWGFX Comparison
Open Charts AGTHX vs RWGFXBanner chart's image
American Funds Growth Fund of Amer A
Price$79.64
Change-$9.51 (-10.67%)
VolumeN/A
Net Assets335.97B
Wedgewood Retail
Price$4.24
Change-$0.66 (-13.47%)
VolumeN/A
Net Assets28.48M
AGTHX vs RWGFX Comparison Chart in %
View a ticker or compare two or three
VS
AGTHX vs. RWGFX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTHX is a Hold and RWGFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AGTHX has more cash in the bank: 336B vs. RWGFX (28.5M). AGTHX pays higher dividends than RWGFX: AGTHX (0.27) vs RWGFX (0.00). AGTHX was incepted earlier than RWGFX: AGTHX (52 years) vs RWGFX (15 years). RWGFX (1.32) is less costly to investors than AGTHX (0.59). AGTHX is a more actively managed with annual turnover of: 32.00 vs. RWGFX (23.00). AGTHX has a lower initial minimum investment than RWGFX: AGTHX (250) vs RWGFX (1000). AGTHX annual gain was more profitable for investors over the last year : 2.79 vs. RWGFX (-10.92). AGTHX return over 5 years is better than : 13.79 vs. RWGFX (-8.82).
AGTHXRWGFXAGTHX / RWGFX
Total Expense Ratio0.591.2547%
Annual Report Gross Expense Ratio0.591.3245%
Fund Existence52 years15 years-
Gain YTD-1.0190.474-215%
Front Load6%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets336B28.5M1,178,947%
Annual Yield % from dividends0.270.00-
Returns for 1 year2.79-10.92-26%
Returns for 3 years45.1713.37338%
Returns for 5 years13.79-8.82-156%
Returns for 10 years120.70-71.45-169%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYMR77.221.60
+2.12%
Kymera Therapeutics
BUD73.531.08
+1.49%
Anheuser-Busch INBEV SA/NV
SVRN0.95N/A
+0.23%
OceanPal Inc.
SPOK13.48-0.17
-1.25%
Spok Holdings
NVCR11.84-0.35
-2.87%
NovoCure Limited